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Objective To examine13 Salmonella typhimurium and 22 S. enteritidis strains isolated from individual cases of
gastroenteritis for their phage types, antibiotic susceptibilities and plasmid pro¢les.
Methods The phage typing of S. typhimurium strains was done according to themethod of Anderson et al,
and the phage typing scheme ofWard et alwas used for phage typing of S. enteritidis strains. Antibiotic
susceptibility testing was performed by the Kirby^Bauer disk di¡usionmethod. Extended-spectrum b-
lactamase production of the strains was determined by the three-dimensional method. Plasmid pro¢les of
the strains were examined using themethod described byKado and Liuwith somemodi¢cation byGraeber
et al.
Results Two S. typhimurium strains were DT193 and onewas DT 22, whereas10 strains were untypable.
PT 4was the predominant phage type among S. enteritidis strains. Four S. enteritidis strains were DT 6a, three
strains were PT1and one strainwas PT 8, whereas onlyone strainwas untypable. Eleven of13 S.
typhimurium and three of 22 S. enteritidis strains were found to bemultiresistant.Ten di¡erent resistance
patterns among S. typhimurium and four di¡erent resistance patterns among S. enteritidis strains were
detected. Extended-spectrum b-lactamase productionwas detected in10 of13 S. typhimurium and in three of
22 S. enteritidis strains. All S. typhimurium strains but onewere found to contain at least one plasmid, with
molecular masses varying between 4 and107MDa, and11di¡erent plasmid patterns were determined.
Plasmid pattern analysis permitted further di¡erentiation of the S. enteritidis strains into nine groups. A
serovar-speci¢c virulence plasmid of 36MDawas detected in13 of 22 S. enteritidis strains.
Conclusions The results suggest that the majority of S. typhimurium strains were closely related.
Keywords Salmonella typhimurium, Salmonella enteritidis, phage type, antibiotic susceptibility, plasmid
pro¢le
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I N T R O D U C T I O N
Non-typhoidal salmonellae are widespread in nature and are
major causes of food poisoning throughout the world [1,2].
For many years, Salmonella typhimuriumwas the most common
serotype isolated, but since the 1980s it has been overtaken by
S. enteritidis [3]. Particularly in developing countries, non-
typhoidal salmonellosis is endemic and of great importance.
However, salmonellosis also still emerges sporadically as a ser-
ious threat against public health in developed countries.
Multiresistant S. typhimurium clones such as DT 204c and,
more recently, DT 104 have appeared and spread in the 1980s
and 1990s [4^6]. Although S. enteritidis is largely sensitive,
resistant strains have been isolated [7^9].
Extended broad-spectrum b-lactamases (ESBLs) have
been reported previously in strains of Salmonella fromTurkey
[10], Argentina [11,12], Latvia [13], Spain [14] andRussia [15].
The present study aimed to investigate the phage types,
antibiotic susceptibilities, ESBL production and plasmid
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pro¢les in S. typhimurium and S. enteritidis strains isolated
from fecal specimens obtained from sporadic cases of gastro-
enteritis in Istanbul,Turkey.
Unfortunately, in Turkey there is no national Salmonella
center to provide reliable statistical data for Turkish isolates.
Therefore, epidemiologic data on Salmonella strains isolated in
Turkey can be obtained only through the collection of ¢nd-
ings obtained from individual studies, and the purpose of our
studywas to conduct one of these.
M A TE R IA L S A N D M E TH O D S
Phage typing
Phage types of S. typhimurium strains were determined by
Anderson's method with 31 type phages and ¢ve additional
type phages [16]; phage types of S. enteritidis strains were deter-
mined by use of the system described byWard et al [17].
Antibiotic susceptibility
Isolates were tested by the disk di¡usion method on Muel-
ler^Hinton Agar (Oxoid Ltd, Basingstoke, UK) according to
the current recommendations of the National Committee for
Clinical Laboratory Standards for susceptibility to the follow-
ing antimicrobial agents [18]: ampicillin, ampicillin^sulbac-
tam, ceftriaxone, cefodizime, cefotaxime, ceftazidime,
cefuroxime, aztreonam, gentamicin, tobramycin, netilmicin,
amikacin, kanamycin, tetracycline, cipro£oxacin, o£oxacin,
chloramphenicol, and sulfonamide.
An isolate was de¢ned as resistant if it was resistant to at
least one of the tested antimicrobial agents, andmultiply resis-
tant if it was resistant tomore than one antimicrobial agent.
ESBL production was tested by the three-dimensional
method of Thomson et al [19].
Plasmid pro®le analysis
Plasmid DNA was extracted by an alkaline lysis procedure
described by Kado and Liu [20] and modi¢ed by Graeber et al
[21].The isolated DNAwas electrophoresed for 2.5 h at 35mA
on a 0.8% horizontal agarose gel in Tris-Boric acid^EDTA
(TBE) bu¡er. After the gels were stained with ethidium bro-
mide, they were photographed under UV illumination. The
approximate molecular masses of plasmids in megadaltons
were determined by comparison with plasmids of 112, 62, 36
and 4.2MDa.
R ES U L T S
The phage types, antibiotic resistance patterns and plasmid
pro¢les of 13 S. typhimurium strains are presented in Table1. Ta
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Two of the 13 S. typhimurium strains were DT 193, and one
strain was DT 22, whereas 10 strains were not typable. Only
two strains were sensitive to all the antibiotics tested.Ten dif-
ferent antibiotic resistance patterns were observed. All resis-
tant strains were resistant to ampicillin and ampicillin^
sulbactam. On the other hand, all S. typhimurium strains were
sensitive to imipenem, cipro£oxacin and o£oxacin. Multiple
resistance was observed in 11 of the 13 S. typhimurium strains.
ESBL production was detected in 10 of 13 S. typhimurium
strains.
All S. typhimurium strains but one were found to harbor at
least one plasmid.The plasmid pro¢les di¡ered greatly among
the strains that carried more than one plasmid. Nine strains
were found to contain more than one plasmid, and four of
these nine strains harbored more than two plasmids.The sizes
of the plasmids ranged from 36 to 107MDa. Only a small
number of strains possessed the virulence plasmid. No single
plasmid was common to all or even most of the strains. Eight
strains carried plasmids of the same approximate molecular
mass, 59^43MDa. Eleven di¡erent plasmid pro¢les were
identi¢ed in S. typhimurium isolates.
The phage types, antibiotic susceptibilities and plasmid
pro¢les of 22 S. enteritidis strains are presented in Table 2.
Twenty-one of the 22 S. enteritidis strains were assigned to four
di¡erent phage types; only one strain was not typable. The
most common phage type was PT 4, represented by 13
strains.
Seventeen of the strains were sensitive to all the antibiotics
tested, and two strains were resistant to ampicillin. Further-
more, multiple resistance, including resistance to ampicillin,
was observed in three of the isolates that were found to pro-
duce ESBL.One of themultiply resistant strainswas also resis-
tant to cipro£oxacin and o£oxacin.
It was estimated that14 S. enteritidis isolates contained a sero-
var-speci¢c virulence plasmid of 36MDa. Eighteen of the 22
S. enteritidis strains were found to carry only one plasmid. Four
strains harbored more than one plasmid, with sizes ranging
from 2 to 100MDa. Nine di¡erent plasmid pro¢le patterns
were identi¢ed among S. enteritidis isolates.
D I S C U S S IO N
In this report, we describe the phage types, antibiotic suscept-
ibilities and plasmid pro¢les of S. typhimurium and S. enteritidis
strains isolated from fecal specimens obtained from sporadic
cases of gastroenteritis in Istanbul.
Phage-typing data on 13 S. typhimurium strains indicated
no special prevalence.Two of the strains were DT 193 and one
strainwas DT 22, whereas 10 strains could not be typed. Phage
typing of S. typhimurium isolates in Turkey has not been
attempted. There are only two studies reporting the phage
types of S. typhimurium strains in Turkey. In one of these stu-
dies, Berkman reported in 1982 that a `few'of 1167 S. typhimur-
ium strains belonged to DT 208 and a `few' strains to DT 135,
whereas all other strains could not be typed because of the pre-
sence of an FI me group resistance plasmid [22]. In the other
study, performed by Diren, it was shown that 51of 80 S. typhi-
murium strains examined were untypable, whereas 15 strains
were DT 193, four strains DT 170a, three strains DT 167, three
strains DT 170, three strains DT 208 and one strain DT 10
[23].
S. typhimurium DT 193 strains isolated in the UK, initially
from calves and cattle and then also from humans, were
shown to be multiply resistant. The main resistance patterns
reported were ACKSSuT [24], ACKSSuTTmNx and
ACKSSpSuTTm [25].The resistance patterns of DT193 strains
investigated by Diren in Turkey were ACKSSuT (eight
strains), CKSSuTG (three strains), AKSSuT (one strain),
CKSSuT (one strain), and ACKSSuSpTG (one strain); one
strainwas sensitive to all antibiotics tested [23]. One of the DT
193 strains investigated in our study was resistant to ampicil-
lin, ampicillin^sulbactam, cefuroxime, cefodizime, cefotax-
ime, ceftazidime, cefoxime, aztreonam, gentamicin,
kanamycin, tobramycin, netilmicin, amikacin, sulfonamide
and chloramphenicol.The other DT193 strain was resistant to
ampicillin, ampicillin^sulbactam, cefuroxime, ceftazidime,
cefoxime, amikacin, gentamicin, netilmicin, tobramicin, sul-
fonamide, chloramphenicol and tetracycline. Both of the
strains were found to produce ESBL.
Multiply resistant S. typhimurium strains have been isolated
with increasing frequency since the 1980s. According to two
country-based studies conducted by the Centers for Disease
Control (CDC) in 1979 and 1984, the overall frequency of
resistance in salmonellae increased from 16% to 24%; how-
ever, it was noted that not all serotypes becamemore resistant,
and the frequency of resistance of S. typhimurium strains
increased, particularly to tetracycline and chloramphenicol.
As seen in the example of chloramphenicol and some other
antibiotics used in livestock production and animal husban-
dry, the bacteria very quickly becamemore resistant [26].
In a study conducted in 1968 inTurkey, it was reported that
resistance to streptomycin, chloramphenicol, kanamycin and
tetracycline was increased in Salmonella strains [27]. In another
study in 1980, resistance to ampicillin, co-trimoxazole, chlor-
amphenicol and tobramycin was seen in 14.5%, 14.5%, 49%
and 3.6% of the Salmonella strains, respectively; no gentamicin
and amikacin resistance was reported [28]. However, in 1981
the multiresistance frequency in S. typhimurium strains was
reported as 96% and 74% from two di¡erent centers. This
study was also the ¢rst report on gentamicin resistance (34%)
in Salmonella in Turkey [29]. Gentamicin resistance was ¢rst
reported in S. typhimurium strains in 1982 in Europe, and the
resistancewas shown to be transferable [30].
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Cipro£oxacin resistance in S. typhimurium strains isolated
inTurkey has not yet been reported. In the present study, it was
found that only one S. enteritidis strain was resistant to cipro-
£oxacin. No cipro£oxacin resistance was seen in the S. typhi-
murium strains investigated.
Cipro£oxacin resistance in S. typhimuriumwas ¢rst reported
byHof et al [31].
Frost et al reported on the increasing occurrence of resis-
tance to cipro£oxacin in salmonellae from humans in England
and Wales between 1991 and 1994, particularly in serotypes
Virchow, Hadar and New Port [32]. Threlfall et al compared
the ¢ndings on resistance in non-typhoidal salmonellae from
humans in 1996 with those isolated in 1994. An increase in the
incidence of resistant strainswas noted, particularly in S. typhi-
murium, S. Hadar and S.Virchow [33].Threlfall et al reported in
1999 on the particular importance of the occurrence of resis-
tance in multiresistant S. typhimurium DT104 and also in S.
Virchow. It was suggested that there is a strong association
between the increase in the occurrence of cipro£oxacin resis-
tance and the licensing for veterinary use of enro£oxacin
[34].
We relate the high incidence of resistance in S. typhimurium
strains isolated from humans inTurkey to the fact that broad-
spectrum antibiotics as well as narrow-spectrum antibiotics
are used in great amounts and irrationally for the treatment of
infectious diseases, including gastroenteritis, inTurkey.
ESBLs have been found in strains of Salmonella typhimurium
isolated in Turkey [10], Argentina [11], Latvia [13], Spain [14]
andRussia [15].
Bauernfeind et al described a South American strain of S.
typhimurium carrying conjugative plasmids coding multiple
resistance to third-generation cephalosporins [11].
In our study,10 of the13 S. typhimurium strains were resistant
to expanded-spectrum cephalosporins andwere found to pro-
duce ESBLs.
In this report, we also describe the plasmid pro¢les detected
in strains of S. typhimurium. All strains except one harbored
plasmids.Themajority containedmore than one plasmid. Ele-
ven di¡erent plasmid pro¢les were identi¢ed, and plasmid
sizes ranged from 4 to 107MDa. Only three of the S. typhimur-
ium strains were found to harbor a 62-MDa serovar-speci¢c
plasmid. Only three strains harbored one plasmid. Most
strains had plasmids ranging from 36 to 84MDa in size. Only
a small number of strains possessed the serovar-speci¢c viru-
lence plasmid. Thus, it is highly likely that this plasmid has
been displaced byother plasmids.
The majority of the S. typhimurium isolates were untypable
and multiresistant, and did not possess serovar-speci¢c plas-
mids. This strongly suggests that these strains are closely
related or clonal.
In this study, among 22 S. enteritidis strains, PT 4 (13 strains)
was the predominant phage type. Only one S. enteritidis strain
was untypable, whereas four strains were PT 6a, three strains
PT1and one strain PT18.
It was reported in a previous study in 1992 that, among 23
S. enteritidis strains isolated from patients with gastroenteritis,
six strains belonged to PT 4, six strains to PT 6, ¢ve strains to
PT 6a, one strain to PT 8, and one strain to PT 7. As seen in the
study mentioned above, in that year in Istanbul PT 4 was not
the predominant phage type [35].
In 1994, it was reported that, among the S. enteritidis strains
isolated in Ankara, the predominant phage type was PT 4
[36].
Studies from di¡erent parts of the world support the
hypothesis that there is a clonal relationship between di¡erent
S. enteritidis phage types [37]. In the UK and Europe, PT 4 is
the predominant phage type and is responsible for most food-
borne diseases in humans [38]. Although there was an increase
in the incidence of infections caused by S. enteritidis PT 24 in
England and Wales, this was thought to be part of the epi-
demic spread of PT 4, because PT 24 was derived from PT 4
by acquisition of a resistance plasmid [39].
Many studies indicate that most of the S. enteritidis strains
are susceptible to a wide range of antimicrobial agents. It was
reported that over 99% of S. enteritidis strains isolated in Hong
Kong between 1986 and 1996 were susceptible to 17^19 of the
antibiotics tested [9].
In the present study, in ¢ve strains, three of them PT 6a,
ampicillin resistance occurred.Vatopoulos et al reported that
21 of the 23 ampicillin-resistant strains were identi¢ed as S.
enteritidis PT 6a and that the ampicillin resistance in Greece is
due to the spread of a limited number of clones of S. enteritidis
PT 6a carrying related 34 -MDa resistance plasmids [40]. Tas-
sios et al also reported that ampicillin resistance in S. enteritidis
strains was due to a 34 -MDa plasmid and isolates of human
origin were less resistant than those of animal or food-feed
origin [41]. Three strains were multiply resistant; one of these
was resistant to 10 and the other one to 13 di¡erent antibiotics,
including cipro£oxacin. In the UK, the frequency of cipro-
£oxacin resistance in S. enteritidis isolates was found to increase
from 0.4% in1994 to1.3% in1997 [34].
Blahova et al described the further occurrence of S. enteritidis
producing an ESBLwhichwas transferred [42].The sequential
in vivo acquisition of ESBLs by S. enteritidiswas ¢rst reported
by Barguellil inTunisia.The genes conferring resistance to b-
lactams, aminoglycosides and chloramphenicol were trans-
ferred together byconjugation [43].
In our study, nine di¡erent plasmid pro¢les among the 22
S. enteritidis strains were detected. Only four strains carried
more than one plasmid, and 14 strains were found to harbor a
36-MDa serovar-speci¢c virulence plasmid.
In a study by Brown et al, it was shown that, among 505
human isolates of S. enteritidis, 59 di¡erent plasmid pro¢les
could be distinguished [44], whereas Threlfall et al observed
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23 plasmid pro¢le types in 534 isolates of S. enteritidis in Eng-
land andWales [45].
Phage typing, resistance typing and plasmid pro¢le analysis
aremethods used in epidemiologic studies of strains. Although
phage typing has been used primarily for the epidemiologic
study of salmonellae, it is of little use in places where a small
number of phage types predominates. Environmental condi-
tions and the plasmid contents of strains can a¡ect the sensitiv-
ity of bacteria to infections by phages [39,46,47]. Therefore,
investigation of the antimicrobial susceptibilities, the charac-
teristics of resistant strains and the molecular epidemiology of
the strains is more signi¢cant. In our study, however, it was
shown that, as an epidemiologic marker, antimicrobial sus-
ceptibility patterns do not appear to be as useful as phage types
and plasmid pro¢les, which e¡ectively subtype S. enteritidis
strains, as was also reported byRodrigue et al [7].
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